(88 days)
Not Found
No
The summary describes a mechanical auto-injector and does not mention any AI or ML components or functionalities.
No
The device is used to assist with the administration of drugs, not to treat a condition itself.
No
Explanation: The device description states its purpose is to assist with self-administered subcutaneous injections of pre-filled drug products. There is no mention of it being used to diagnose conditions or diseases.
No
The device description clearly states it is a "single-use, automatic, disposable and hidden-needle auto-injector," which are physical hardware components.
Based on the provided information, the Compact Auto Safety Injector (CASI) is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use of the CASI is to assist in the self-administered subcutaneous injection of drug products. This is a delivery mechanism for medication, not a test performed on a sample taken from the body to diagnose or monitor a condition.
- Device Description: The description clearly states it's an auto-injector for administering liquid drug products.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in those samples
- Providing information for diagnosis, monitoring, or screening
The CASI is a medical device designed to facilitate the delivery of medication, which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
The Compact Auto-Safety Injector (CASI) is indicated for assisting the self administered subcutaneous injection of fixed doses of FDA approved drug products with viscous liquid formulations, which are presented in standard 1ml long BD Hypak® pre-filled syringes with staked needles.
The CASI is primarily intended for home use by patients to aid and support their treatment regime or may be used by Health Care Professionals or caregivers.
Product codes (comma separated list FDA assigned to the subject device)
KZH
Device Description
The CASI is a single-use, automatic, disposable and hidden-needle auto-injector for the self-administration of liquid drug products.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
home use by patients, Health Care Professionals or caregivers
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Extensive design verification, functional and performance testing have been conducted. The information provided in this premarket notification demonstrates that the CASI device is safe and effective for the intended use and is substantially equivalent to the legally marketed predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.6920 Syringe needle introducer.
(a)
Identification. A syringe needle introducer is a device that uses a spring-loaded mechanism to drive a hypodermic needle into a patient to a predetermined depth below the skin surface.(b)
Classification. Class II (performance standards).
0
K073476
1 of 2
| The Medical House | |
|---|---|
| And And Ass " various would of the |
MAR - 7 2008
MEDICAL HOUSE (ASI) LTD
| Pre-Market Notification | Revision No: 02 | |
|---|---|---|
| ------------------------- | -- | ----------------- |
Section 5.0
| Product: Compact Auto-Safety Injector (CASI) | 510(k) Summary | Effective Date: 05 March 2008 |
|---|---|---|
| ---------------------------------------------- | ----------------------- | ------------------------------- |
510(k) Summary [As required by 21 CFR 907.92(a)]
A. Submitter Information:
| Submitter: | Medical House (ASI) Limited
199 Newhall Road
Sheffield, S9 2QJ
United Kingdom |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact person: | Rose Y Guang
Quality, Regulatory Affairs & Operations Director
E-mail: rguang@themedicalhouse.com
Phone: (+) 44 1142 619 011
Fax (+) 44 1142 431 597 |
Date: March 05 2008
B. Device Information:
Trade/ Proprietary Name: Compact Auto-Safety Injector (CASI)
| Common Name: | Auto-Injector |
|---|---|
| Classification Name: | Introducer, syringe needle |
| Predicate Device: | Modification to Autoject Mini K000482 |
| Device Description: | The CASI is a single-use, automatic, disposable |
| and hidden-needle auto-injector for the self- | |
| administration of liquid drug products. | |
| Intended Use: | The Compact Auto-Safety Injector (CASI) is |
| indicated for assisting the self-administered | |
| subcutaneous injection of fixed doses of FDA | |
| approved drug products with viscous liquid | |
| formulations, which are presented in standard 1ml | |
| long BD Hypak® pre-filled syringes with staked | |
| needles. The CASI is primarily intended for home | |
| use by patients to aid and support their treatment | |
| regime or may be used by Health Care Professionals | |
| or caregivers. |
1
K07 3476
2 of 2
| MEDICAL HOUSE (ASI) LTD | ||
|---|---|---|
| Pre-Market Notification | Section 5.0 | |
| 510(k) Summary | Revision No: 02 | |
| Product: Compact Auto-Safety Injector (CASI) | Effective Date: | |
| 05 March 2008 |
C. Comparison of Required Technological Characteristics
The CASI device applies the same technological characteristics as the predicate device. It is designed similarly to the devices that are currently marketed in the U.S.
The key difference of the CASI is that the syringe needle is retracted into the device following injection, rather than remaining exposed or simply covered as in the predicate device. Due to the technological identity and equivalent indications for use of the CASI device and the predicate device, no additional safety items were identified.
D. Summary and Conclusion of Performance Tests
Extensive design verification, functional and performance testing have been conducted. The information provided in this premarket notification demonstrates that the CASI device is safe and effective for the intended use and is substantially equivalent to the legally marketed predicate device.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular, with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is an abstract image of an eagle, with its wings spread. The eagle is facing to the left.
Food and Druq Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Rose Y. Guang Quality, Regulatory Affairs & Operations Director Medical House (ASI) Limited 199/201 Newhall Road Sheffield S9 2QJ UNITED KINGDOM
MAR - 7 2008
Re: K073476
Trade/Device Name: Compact Auto Safety Injector (CASI) Regulation Number: 21 CFR 880.6920 Regulation Name: Syringe Needle Introducer Regulatory Class: II Product Code: KZH Dated: November 30, 2007 Received: December 10, 2007
Dear Ms. Guang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Guang
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chiu-Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
MEDICAL HOUSE (ASI) LTD
| Pre-Market Notification | Section 4.0 | Revision No: 02 |
|---|---|---|
| Product: Compact Auto-Safety Injector (CASI) | Indication For Use Statement | Effective Date: 05 March 2008 |
510(k) Number: K073476
Device Name: Compact Auto Safety Injector (CASI)
Indications For Use:
The Compact Auto Safety Injector (CASI) is indicated for assisting the selfadministered subcutaneous injection of fixed doses of FDA approved drug products with viscous liquid formulations, which are presented in standard 1ml long BD Hypak® pre-filled syringes with staked needles.
The CASI is primarily intended for home use by patients to aid and support their treatment regime or may be used by Health Care Professionals or caregivers.
Prescription Use X (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND (21 CFR 801 Subpart C)
4-1
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Cusack Verna
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K 473476